Rheum Round-up: Interview—Expert Weighs In on Trump Taking Hydroxychloroquine, Biologics and Cancer, and more
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about President Donald Trump’s recent admission...
Do Biologics Increase Melanoma Risk? Jury May Still Be Out
Patients with inflammatory diseases such as rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD) are often placed on biologic therapies for treatment. Questions...
Interview: President Trump’s Decision to Take Hydroxychloroquine
This week, President Donald Trump revealed that he has been taking hydroxychloroquine to help protect himself from COVID-19. The admission sparked controversy, as several...
Rheum Round-up: Hydroxychloroquine Still A Flop for COVID-19, Real-World RA Treatment Comparison, and more
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about more research rejecting hydroxychloroquine as...
Triple Therapy Versus TNFi Plus Methotrexate for Rheumatoid Arthritis: A Real-World Treatment Comparison
A recent study compared real-world outcomes between rheumatoid arthritis (RA) patients treated with triple therapy versus tumor necrosis factor inhibitor (TNFi) plus methotrexate (TNF/MTX)....
Rheum Round-up: Are Arthritis Drugs the Holy Grail of COVID-19?, How The Pandemic Affected...
Here are the top stories recently covered by DocWire News in the Rheumatology section. In this edition, read about trials of rheumatoid arthritis (RA)...
Here’s How Rheumatic Patients Were Affected During the Early Days of the COVID-19 Pandemic
A study evaluated how patients with rheumatic diseases were impacted by the COVID-19 pandemic during its initial stages in the United States.
“Patients with rheumatic...
